Proving that investment yields strategic value
Kramfors municipality in Sweden sought to integrate automated medicine dispensing (AMD) as a key pillar in its strategic long-term care delivery. The objective was not just marginal efficiency, but a measurable positive impact on both staff capacity and client well-being, proving the higher cost of a comprehensive solution was justified.
This case study demonstrates how moving beyond the unit price and investing in Evondos resulted in impact that dramatically exceeded expectations, leading to a final report that recommended immediate, swift roll-out.
The hidden cost of unmet needs
The challenge: Balancing capacity with human value
Kramfors recognised that the rising demand for homecare meant staff were consistently rushed, risking burnout and compromising the quality of human interaction clients deserved. The challenge was twofold:
- Resource constraint: Staff were consumed by routine, low-value medication visits, which severely limited the time available for meaningful care.
- Client independence: The reliance on frequent physical visits undermined the goal of fostering dignity and independence among clients who could manage the dispensing process themselves.
The municipality needed a solution that would deliver a return on investment not just in financial metrics, but in recaptured quality of life for both their employees and their elderly citizens. The only path was a high-value investment in a best-in-class partner.
The goal: Strategic validation for rapid scale
The successful pilot was designed to validate that a premium, high-trust solution, backed by superior support and reliability, could deliver benefits significant enough to warrant a complete shift in care delivery policy. The goal was to secure proof that:
- 1. Quality of life improves: Clients would gain independence and control over their own medication management, delaying expensive and unwanted institutional care.
- 2. Resource planning stabilises: The process would become easier and more predictable for care managers.
- 3. Strategic roll-out is justified: The final evaluation would provide the necessary evidence to commit to a swift, municipality-wide expansion.
Evondos' comprehensive solution
Partnering for validated independence
Kramfors chose the Evondos service because it guaranteed reliability, proven 99% adherence and provided the necessary evidence base to justify a large-scale strategic investment. This platform is more than just hardware; it is an end-to-end partnership.
- Enabling autonomy: The robot gave clients control over taking their medication at the right time, fostering a sense of self-esteem and independence, aligning with the goal of dignified, independent life at home.
- Simplifying staff roles: The automated dispensing relieved staff of the administrative burden and worry over medication adherence, allowing them to redirect their focus during visits, freeing up time for quality care and where "warm hands are needed".
- Building a data narrative: The municipality leveraged the robust reporting and reliability data generated by Evondos to conduct a comprehensive final report that quantified the success of the new approach, providing procurement confidence and aligning with long-term aging strategies.
Shifting workflow to quality interaction
By delegating the routine task of dispensing to Evondos, the care team could re-engineer their visits to focus on human-centric care.
Quantified value: The measurable return on investment
Outcome-driven results
The outcome of the study was a profound validation of the strategic investment, leading the final report to recommend a swift roll-out of the Evondos service.
Outcome-driven care: Independence and wellbeing
The investment directly improved the clients' experience and quality of life:
- Increased independence: Clients gained greater control over their lives, reducing their dependence on external staff for routine, time-sensitive tasks.
- Improved quality of life: The service contributed to a better overall quality of life and reduced the worry associated with medication schedules.
Workforce empowerment: Planning stability
The operational value translated into direct benefits for the care managers and staff:
- Easier resource planning: Care became significantly easier to resource plan, improving logistical efficiency across the municipality.
- Staff focus: Staff were freed to focus on actual care rather than dispensing, increasing their professional satisfaction and reducing the risk of burnout.
Cost-conscious innovation: Validated future investment
The positive validation of the entire process proved the long-term financial wisdom of the investment:
- Exceeding expectations: The overall impact of the medicine dispensing robots exceeded expectations, leading to a strong, definitive recommendation for expansion.
- Strategic adoption: The endorsement of a swift roll-out demonstrates that the cost of the premium solution was definitively justified by the strategic, long-term operational benefits achieved. This investment confirmed that choosing Evondos was the most cost-effective choice in the long run.
Why Kramfors chose investment over a limited solution
For Kramfors, the investment in Evondos was validated by staff and clients: They purchased assured independence for their citizens and a stable, predictable platform for resource planning, proving that exceeding expectations is the truest measure of value.
They chose a partner they could depend on, one that provided real value, safety, and quality care, enabling them to empower citizens to stay independent at home longer, with no compromises.
Ready to see the Evondos impact for yourself? Speak to us today to find out how we can provide the long-term value and strategic partnership needed to future-proof your healthcare service.